NCT00461773View on ClinicalTrials.gov

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Hormone-Sensitive Breast CancerBreast Cancer
Interventions
DRUG

Letrozole

Letrozole 2.5 mg po qd

DRUG

Bevacizumab

bevacizumab 10 mg/kg IV

Trial Locations (1)

06520

Yale University, Yale Cancer Center, New Haven

Sponsors

Collaborators (2)

Novartis
Genentech, Inc.
All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

lead

Yale University

OTHER